本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bicara Therapeutics

23.54
+0.73003.20%
成交量:15.24萬
成交額:353.20萬
市值:15.58億
市盈率:-7.57
高:23.60
開:22.88
低:22.51
收:22.81
52周最高:30.99
52周最低:10.30
股本:6,617.29萬
流通股本:3,676.23萬
量比:0.57
換手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-3.1097
每股收益(LYR):-2.5230
淨資產收益率:-41.01%
總資產收益率:-26.14%
市淨率:3.32
市盈率(LYR):-9.33

資料載入中...

2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/26

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/28

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities